# Bravecto Dose Guide: Fluralaner 12-Week Flea Tick Dose
## Key Takeaways
- Fluralaner, marketed as Bravecto, is an isoxazoline ectoparasiticide providing 12 weeks of flea and tick control via oral (dogs, 25 mg/kg) or topical (cats, 40 mg/kg) administration.
- Its mechanism of action involves antagonizing GABA-gated and glutamate-gated chloride channels in parasites, leading to hyperexcitation and death, with selective toxicity for arthropods over mammals.
- Efficacy against the Australian paralysis tick (*Ixodes holocyclus*) in cats has been demonstrated with a single 40 mg/kg topical dose, providing sustained protection for 12 weeks.
- A critical step before administration is accurate body weight measurement to prevent underdosing, which can lead to treatment failure and increased risk of tick-borne diseases.
- Adverse effects are generally mild and transient, but neurologic signs (tremors, ataxia, seizures) have been reported, particularly in pets with a pre-existing seizure history, necessitating careful risk-benefit assessment by a veterinarian.
- The prolonged half-life of fluralaner, facilitated by tissue distribution and enterohepatic recirculation, is the pharmacokinetic basis for its 12-week duration of action, maintaining therapeutic concentrations from a single dose.
---
Fluralaner, marketed as Bravecto, is a systemic isoxazoline ectoparasiticide approved for the treatment and prevention of flea and tick infestations in dogs and cats. The standard label dose for dogs is 25 mg/kg body weight administered orally, providing up to 12 weeks of tick and flea control. For cats, a topical spot-on formulation is approved at a dose of 40 mg/kg body weight, also offering 12 weeks of protection against fleas and ticks, including the Australian paralysis tick (*Ixodes holocyclus*) [1]. This guide provides a comprehensive, source-grounded review of fluralaner dosing, efficacy, safety, and clinical application for veterinary professionals and pet owners.
**Owner-Facing Triage Summary:** If you are considering Bravecto for your pet, the most critical step is obtaining an accurate body weight. The dose is calculated strictly on weight, and underdosing can lead to treatment failure and increased risk of tick-borne disease. For dogs, Bravecto is given as a chewable tablet by mouth. For cats, Bravecto is applied topically to the skin at the back of the neck. Do not administer a [dog](/knowledge/veterinary-medicine/clinical-methods/dog) product to a [cat](/knowledge/veterinary-medicine/clinical-methods/cat). Contact your veterinarian to confirm the correct product formulation and dose for your pet's specific weight. If your pet shows signs of neurological abnormalities (tremors, ataxia, seizures), vomiting, or severe lethargy after administration, contact a veterinary emergency facility immediately.
## At a Glance: Fluralaner (Bravecto) Dosing and Key Characteristics
| Feature | Canine (Bravecto Chew) | Feline (Bravecto Spot-On) |
| :--- | :--- | :--- |
| **Active Ingredient** | Fluralaner (Isoxazoline) | Fluralaner (Isoxazoline) |
| **Route of Administration** | Oral (chewable tablet) | Topical (spot-on) |
| **Target Dose** | 25 mg/kg | 40 mg/kg [1] |
| **Duration of Efficacy** | 12 weeks (fleas & ticks) | 12 weeks (fleas & ticks) [1] |
| **Onset of Action** | Kills fleas within 8 hours, ticks within 12 hours (label claim) | Kills fleas within 12 hours, ticks within 48 hours (label claim) |
| **Primary Mechanism** | GABA-gated chloride channel antagonist | GABA-gated chloride channel antagonist |
| **Key Advantage** | Long duration reduces dosing frequency | Long duration; systemic action effective against paralysis tick [1] |
| **Prescription Required?** | Yes (in most regions) | Yes (in most regions) |
## Understanding Fluralaner and the 12-Week Dose
Fluralaner belongs to the isoxazoline class of ectoparasiticides. Its mechanism of action involves antagonizing insect and acarine GABA-gated chloride channels and glutamate-gated chloride channels. This blockade causes hyperexcitation of the parasite's nervous system, leading to rapid death. The selective toxicity of isoxazolines for parasites over mammals is due to differences in receptor sensitivity.
The 12-week duration of action is a defining feature of fluralaner. Unlike many monthly preventives, fluralaner's long half-life in dogs and cats allows for a single dose to provide effective plasma concentrations for up to three months. This extended interval offers convenience and can improve compliance, ensuring continuous protection against fleas and ticks.
The approved dose for dogs is 25 mg/kg, and for cats, it is 40 mg/kg [1]. These doses were established through controlled efficacy studies to ensure rapid and sustained kill of target parasites. The higher dose in cats reflects species-specific pharmacokinetic differences and the need to achieve effective systemic concentrations via topical application.
## Approved Sources and Clinical Evidence
The efficacy and safety of fluralaner are supported by a substantial body of research. Two key studies provide foundational evidence for its use.
### Efficacy Against Ixodes holocyclus in Cats
A pivotal study by Fisara et al. (2018) investigated the efficacy of fluralaner spot-on (Bravecto) against infestations of the Australian paralysis tick, *Ixodes holocyclus*, in cats [1]. This tick species is a significant threat in Australia due to the potentially fatal paralysis caused by a toxin in its saliva. The study involved two groups of 10 cats: one group received a single topical dose of fluralaner at 40 mg/kg, and the other served as an untreated control. All cats were infested with adult female *I. holocyclus* ticks on Day -1 and then again on Days 14, 28, 42, 56, 70, and 84 post-treatment. The study demonstrated that a single topical administration of fluralaner at 40 mg/kg was highly effective against existing infestations and provided sustained protection against subsequent re-infestations for the full 12-week study period [1]. This research is crucial because it addresses a gap in published data on preventive measures for this dangerous tick species, confirming that fluralaner is a viable option for cats in endemic areas [1].
### Baseline Susceptibility in Cattle Ticks
While not a direct study on companion animals, research by Klafke et al. (2025) standardized larval bioassays to determine fluralaner susceptibility in *Rhipicephalus microplus*, the cattle tick [2]. This study is significant for establishing baseline susceptibility data and resistance monitoring protocols. The researchers found that *R. microplus* populations from Brazil and Argentina were highly susceptible to fluralaner, with resistance ratios near unity in all field samples [2]. The study also highlighted methodological differences, noting that the larval immersion test (LIT) produced LC50 values approximately 100 times lower than the larval packet test (LPT) [2]. This finding underscores the importance of standardized testing for monitoring potential resistance development, a concern for any acaricide. Although this study focuses on cattle, it confirms the potent acaricidal activity of fluralaner and provides a framework for understanding susceptibility across tick species [2].
## Veterinary Examination and Diagnostics
Before prescribing Bravecto, a veterinarian should perform a thorough examination. This includes:
1. **Body Weight Measurement:** An accurate weight is mandatory for calculating the correct dose. The dose is weight-based, and using an estimated weight can lead to underdosing.
2. **Health Status Assessment:** The veterinarian will assess the pet's overall health, including checking for any signs of systemic disease, neurological disorders, or a history of seizures. While fluralaner is generally safe, a risk-benefit analysis is recommended for pets with a known seizure history.
3. **Parasite Identification:** If the pet has a flea or tick infestation, the veterinarian may identify the specific species. This is particularly important in regions with vectors of serious diseases, such as Lyme disease (transmitted by *Ixodes* ticks) or Australian paralysis tick.
4. **Concurrent Medication Review:** The veterinarian will review all other medications, supplements, or topical products the pet is receiving to check for potential interactions.
## Evidence-Based Management and Administration
### Canine Administration (Oral)
Bravecto chewable tablets are administered orally. The tablet can be given with or without food, but administration with food may enhance absorption. It is important to ensure the entire dose is consumed. If the dog vomits within a few hours of administration, the dose may not be fully absorbed, and the veterinarian should be consulted to determine if a re-dose is necessary.
### Feline Administration (Topical)
Bravecto spot-on for cats is applied topically. The contents of the tube should be applied directly to the skin at the base of the skull, parting the fur. It is critical to apply to the skin, not just the hair, to ensure proper absorption. The application site should not be bathed or shampooed for a specified period (usually 24-48 hours) to allow for optimal distribution.
### Dosing Frequency
The label recommends administration every 12 weeks. However, in high-risk areas or situations with heavy tick pressure, a veterinarian might recommend more frequent administration (e.g., every 8 weeks) for optimal control. This is an off-label adjustment that should only be made under veterinary guidance. For flea allergy dermatitis (FAD), a 12-week interval is often sufficient to break the flea life cycle, but the veterinarian may adjust the schedule based on the severity of the allergy.
## Unsafe Home Remedies and Misconceptions
It is crucial to warn pet owners against unsafe practices:
- **Never use dog products on cats.** Dog formulations of isoxazolines can be toxic to cats due to differences in metabolism and concentration. The feline spot-on is specifically formulated for cats.
- **Do not split tablets.** Bravecto tablets are not scored for splitting, and splitting can lead to inaccurate dosing. The tablets are designed to be given whole.
- **Avoid using expired products.** Expired products may have reduced efficacy.
- **Do not apply topical products to broken or irritated skin.** This can increase systemic absorption and risk of adverse effects.
- **Avoid "natural" alternatives without veterinary approval.** Many home remedies are ineffective and can be harmful.
## Risk Factors and Adverse Effects
Fluralaner is generally well-tolerated. The most commonly reported adverse effects in dogs are mild and transient, including vomiting, decreased appetite, diarrhea, lethargy, and flatulence. In cats, the most common adverse effects are mild and transient, including vomiting, pruritus (itching) at the application site, alopecia, and diarrhea.
A significant consideration is the use of isoxazolines in pets with a history of seizures. The U.S. FDA has issued a warning that isoxazoline drugs, including fluralaner, have been associated with neurologic adverse reactions in some dogs and cats, including muscle tremors, ataxia, and seizures. The risk appears to be higher in pets with a pre-existing history of neurological disorders. Therefore, the decision to use fluralaner in such pets must be a careful risk-benefit analysis performed by the veterinarian.
**Emergency Red Flags:** Seek immediate veterinary care if your pet exhibits any of the following after administration:
- Seizures or tremors
- Severe ataxia (incoordination) or difficulty walking
- Profound lethargy or collapse
- Repeated vomiting or diarrhea (especially with signs of dehydration)
- Facial swelling, hives, or difficulty breathing (signs of an allergic reaction)
## Prevention and Prognosis
The prognosis for pets treated with fluralaner is excellent. It is a highly effective preventive when used correctly. By providing 12 weeks of continuous protection, it significantly reduces the risk of flea-borne and tick-borne diseases.
Prevention strategies should include:
- **Year-round protection:** In many regions, fleas and ticks are active year-round. Consistent use of a preventive is recommended by organizations like the Companion Animal Parasite Council (CAPC).
- **Environmental control:** For flea infestations, treating the pet is only half the battle. The environment (home, yard) must also be treated to eliminate flea eggs, larvae, and pupae.
- **Tick checks:** Even with preventive use, it is good practice to check pets for ticks after being outdoors, especially in wooded or grassy areas. Prompt removal of ticks reduces the risk of disease transmission.
## Limitations and When to Contact a Veterinarian
This guide provides general information. It cannot predict individual responses to medication. Breed-level information cannot predict how a specific animal will metabolize or react to a drug. The dose must be confirmed by a veterinarian based on the pet's exact body weight and health status.
**Contact your veterinarian if:**
- You are unsure about the correct dose or product formulation.
- Your pet has a history of seizures or other neurological conditions.
- Your pet is pregnant, nursing, or intended for breeding (safety in these cases has not been fully established).
- Your pet experiences any adverse effects after administration.
- You are considering using Bravecto in conjunction with other medications.
## Clinical Pharmacology and Pharmacokinetic Rationale for the 12-Week Interval
Understanding why fluralaner provides 12 weeks of protection requires a closer look at its pharmacokinetic profile, which differs meaningfully from older ectoparasiticides. Fluralaner is highly lipophilic, which allows it to distribute extensively into body tissues and then slowly release back into the systemic circulation. This tissue reservoir effect is the primary reason a single oral dose in dogs maintains therapeutic plasma concentrations for approximately 84 days. The drug also undergoes enterohepatic recirculation, meaning it is excreted into the bile and then reabsorbed from the intestine, further prolonging its presence in the bloodstream.
The clinical implication of this prolonged half-life is that steady-state concentrations are not required for efficacy. Unlike monthly products that rely on repeated dosing to maintain a therapeutic trough, fluralaner achieves and sustains effective concentrations from a single administration. This pharmacokinetic feature also explains why the drug continues to kill newly acquired fleas and ticks throughout the entire dosing interval. When a tick attaches and begins to feed, it ingests blood containing fluralaner. The drug then binds to the tick's GABA-gated chloride channels, causing hyperexcitation, paralysis, and death before the tick can transmit most vector-borne pathogens.
For cats, the topical formulation relies on systemic absorption through the skin rather than local distribution along hair follicles. The drug is absorbed into the bloodstream and distributed systemically, which is why it is effective against the Australian paralysis tick that attaches at various body sites [1]. The higher label dose of 40 mg/kg in cats compared to 25 mg/kg in dogs reflects both species-specific differences in drug clearance and the need to achieve adequate systemic concentrations after percutaneous absorption. Owners should understand that the topical product is not a barrier repellent; it does not prevent ticks from attaching. Instead, it kills them after they begin feeding, which is why the onset of tick death is slightly slower in cats (48 hours) compared to dogs (12 hours).
## Diagnostic Workup Before Initiating Fluralaner Therapy
A responsible veterinary visit for Bravecto administration involves more than a weight check and a prescription refill. The clinician should perform a structured assessment to identify any contraindications, drug interactions, or underlying conditions that could influence the safety or efficacy of fluralaner.
### Signalment and History Review
The veterinarian should confirm the species, breed, age, and reproductive status of the patient. Fluralaner is approved for use in dogs and cats, but the formulations are species-specific. A kitten or puppy younger than the labeled age minimum should not receive the product. The clinician should also ask about any prior adverse reactions to isoxazoline products, as cross-reactivity within the drug class is possible. A history of seizures, myoclonus, or other neurologic signs warrants a detailed discussion of the FDA warning regarding isoxazolines and neurologic adverse events.
### Physical Examination Priorities
The physical examination should focus on several organ systems. A neurologic examination is essential, including assessment of gait, proprioception, cranial nerve function, and spinal reflexes. Even subtle abnormalities such as mild ataxia or a decreased menace response may influence the decision to use fluralaner. Dermatologic examination is also important, particularly in cats, to ensure the application site is free of lesions, matting, or irritation. The skin at the base of the skull should be intact, as application to broken skin can increase systemic absorption and the risk of adverse effects.
### Laboratory Testing Considerations
Routine laboratory testing is not required before fluralaner administration in healthy animals. However, for geriatric pets or those with suspected hepatic or renal disease, baseline blood work may be prudent. Fluralaner is metabolized in the liver and excreted in both urine and feces. Severe hepatic dysfunction could theoretically alter drug clearance, although no specific dose adjustment guidelines exist. For pets with chronic kidney disease, the clinician should weigh the potential benefits of tick-borne disease prevention against the lack of safety data in this specific population.
### Parasite Identification and Vector Risk Assessment
If fleas or ticks are found on the pet, the veterinarian should identify the species when possible. This is not merely academic; different tick species carry different pathogens. For example, *Ixodes scapularis* transmits *Borrelia burgdorferi* (Lyme disease) and *[Anaplasma phagocytophilum](/knowledge/bacteria/pet-bacteria/anaplasma-phagocytophilum)*, while *Rhipicephalus sanguineus* transmits *[Ehrlichia canis](/knowledge/bacteria/pet-bacteria/ehrlichia-canis)* and *Babesia vogii*. In Australia, *Ixodes holocyclus* is unique because its saliva contains a neurotoxin that causes ascending paralysis, which can be fatal if untreated [1]. Knowing which parasites are endemic in the region helps the veterinarian determine whether a 12-week interval is sufficient or whether more frequent dosing is warranted during peak tick season.
## Evidence Limitations and Gaps in Current Knowledge
While the existing evidence base for fluralaner is robust, several limitations deserve acknowledgment. The pivotal feline study by Fisara et al. (2018) enrolled a relatively small number of animals, with 10 cats in each treatment group [1]. While the results were statistically significant and clinically compelling, small sample sizes can limit the generalizability of findings. The study was also conducted under controlled [laboratory conditions](/knowledge/diagnostics/molecular/laboratory-conditions) with deliberate tick infestations, which may not fully replicate the variability of natural exposure in a home environment.
The cattle tick study by Klafke et al. (2025) provides valuable baseline susceptibility data, but it also highlights an important methodological concern [2]. The larval immersion test produced LC50 values approximately 100 times lower than the larval packet test, indicating that the choice of bioassay can dramatically influence results [2]. This discrepancy matters because resistance monitoring programs rely on consistent methodology to detect emerging resistance. If different laboratories use different assays, comparing results across studies becomes difficult. For companion animal practitioners, this means that while fluralaner currently shows excellent efficacy against a broad range of tick species, ongoing surveillance is needed to detect any future resistance development.
Another evidence gap relates to the safety of fluralaner in breeding, pregnant, or lactating animals. The label states that safety has not been fully established in these populations. While no teratogenic effects have been reported in laboratory animals, the absence of evidence is not evidence of absence. Veterinarians should exercise caution when considering fluralaner for pregnant or nursing females and should discuss the theoretical risks with the owner before proceeding.
Finally, most efficacy studies evaluate fluralaner as a monotherapy. Real-world use often involves concurrent medications, including heartworm preventives, antibiotics, or immunosuppressive drugs. While no clinically significant drug interactions have been reported, the potential for interactions with drugs that affect the cytochrome P450 enzyme system has not been systematically studied. Owners should always disclose all medications and supplements to their veterinarian.
## Owner Observation and Preparation for the Veterinary Visit
Pet owners play a critical role in the safe and effective use of fluralaner. Preparation before the veterinary visit can streamline the consultation and ensure that all relevant information is available.
### What to Bring to the Appointment
Owners should bring a complete list of all medications, including prescription drugs, over-the-counter products, supplements, and topical treatments. This includes flea and tick products that may have been used previously, as well as heartworm preventives. If the pet has experienced any adverse reactions to prior medications, this should be documented. Owners should also bring any previous medical records, especially if the pet has a history of seizures, neurologic disorders, or allergic reactions.
### Questions to Ask the Veterinarian
Owners should be encouraged to ask specific questions during the visit. These might include:
- What is the exact weight of my pet, and which tablet or tube size will be used?
- How should I administer the dose, and what should I do if my pet spits out the tablet or vomits afterward?
- How quickly should I expect to see a reduction in fleas or ticks?
- What signs should I watch for that might indicate an adverse reaction?
- Is a 12-week interval appropriate for my pet's lifestyle and geographic location, or should we consider more frequent dosing?
- Should I be concerned about the FDA warning regarding seizures?
- What should I do if my pet has a severe infestation, and will I need additional products to treat the environment?
### Observing the Pet After Administration
After the dose is administered, owners should monitor their pet for the first 24 to 48 hours. Mild and transient gastrointestinal signs such as vomiting, decreased appetite, or diarrhea can occur, particularly in dogs. In cats, the most common adverse effects are vomiting and transient pruritus or alopecia at the application site. Owners should also observe for any neurologic signs, including muscle tremors, ataxia, or seizures. While these events are rare, they require immediate veterinary attention.
Owners should also be advised that a single dose will not immediately eliminate a heavy flea infestation. It may take several days for the drug to kill all adult fleas on the pet, and the environment may still contain flea eggs, larvae, and pupae. A comprehensive flea control plan should include environmental treatment and possibly a household insect growth regulator.
## Prevention Strategies and Integrated Parasite Management
Fluralaner is a powerful tool, but it is most effective when integrated into a broader parasite prevention strategy. The Companion Animal Parasite Council recommends year-round broad-spectrum parasite control for all pets, regardless of geographic location. This includes protection against fleas, ticks, heartworms, and [intestinal parasites](/knowledge/parasites/pet-parasites/intestinal-parasites-dogs-cats-identification-treatment).
### Year-Round Versus Seasonal Use
Many owners assume that flea and tick prevention is only necessary during warm months. This is a misconception. In many regions, fleas can survive indoors year-round, and ticks may become active whenever temperatures rise above freezing. Even in colder climates, a winter thaw can trigger tick activity. The 12-week duration of fluralaner means that a single dose can cover an entire season in some regions, but year-round use is still recommended for consistent protection.
### Environmental Control for Flea Infestations
For pets with a heavy flea infestation, treating the animal is only part of the solution. Flea eggs, larvae, and pupae can persist in the environment for months. A comprehensive approach includes:
- Vacuuming carpets, rugs, and upholstery frequently, and disposing of the vacuum bag immediately.
- Washing pet bedding in hot water weekly.
- Using an environmental flea spray or fogger that contains an insect growth regulator (IGR) to prevent immature fleas from developing into adults.
- Treating outdoor areas where the pet spends time, such as shaded spots under porches or decks.
### Tick Checks and Safe Removal
Even with fluralaner, owners should perform regular tick checks after their pet has been outdoors, especially in wooded, grassy, or brushy areas. Ticks can attach to any part of the body, but they are commonly found around the head, ears, neck, and between the toes. If a tick is found, it should be removed promptly using fine-tipped tweezers. The tick should be grasped as close to the skin as possible and pulled straight out with steady, even pressure. The bite site should be cleaned with antiseptic. Owners should avoid squeezing the tick's body, as this can inject more saliva into the pet.
### The Role of Fluralaner in Preventing Tick-Borne Disease
The speed of kill is a critical factor in preventing tick-borne disease transmission. For many tick-borne pathogens, transmission does not occur immediately after attachment. For example, *Borrelia burgdorferi* (Lyme disease) typically requires 24 to 48 hours of attachment before transmission occurs. Fluralaner kills ticks within 12 hours in dogs, which is faster than the transmission time for most pathogens. This rapid speed of kill provides a significant margin of safety. However, it is not absolute, and owners should not rely solely on the medication to prevent all tick-borne diseases. Regular tick checks and prompt removal remain important.
## Special Population Considerations
Certain populations require additional thought when prescribing fluralaner.
### Puppies and Kittens
Fluralaner is approved for use in puppies and kittens at specific minimum ages. The exact age minimum varies by region and formulation, so the veterinarian should confirm the label indication. Young animals may be more sensitive to the neurologic effects of isoxazolines, and the risk-benefit analysis should be discussed with the owner. For very young puppies or kittens, a monthly product with a shorter duration of action may be considered as an alternative.
### Geriatric Pets
Older pets often have concurrent health conditions, including chronic kidney disease, hepatic insufficiency, or cognitive dysfunction. While fluralaner is generally well-tolerated in geriatric patients, the veterinarian should assess organ function and consider whether the prolonged half-life of the drug is appropriate. A geriatric pet with a history of seizures may be at higher risk for neurologic adverse events, and alternative products should be discussed.
### Pets with a History of Seizures
The FDA warning regarding isoxazolines and neurologic adverse events is a significant consideration. The warning states that muscle tremors, ataxia, and seizures have been reported in dogs and cats receiving isoxazoline products, and that the risk may be higher in pets with a history of neurologic disorders. For a pet with well-controlled epilepsy, the veterinarian may still recommend fluralaner if the benefits of tick-borne disease prevention outweigh the risks. However, the owner should be fully informed of the potential for a breakthrough seizure and should have a plan in place for emergency care.
### Pregnant or Nursing Females
Safety in pregnant, lactating, or breeding animals has not been fully established. The veterinarian should discuss the theoretical risks with the owner and consider alternative products with more established safety profiles in these populations. If fluralaner is used, the owner should be advised to monitor the dam and offspring closely.
### Cats with Outdoor Access
Cats that spend time outdoors are at higher risk for flea and tick infestations, as well as exposure to the Australian paralysis tick in endemic regions [1]. For these cats, the 12-week duration of fluralaner provides convenient and consistent protection. However, owners should understand that the topical product is not a repellent, and ticks may still attach before being killed. Regular grooming and tick checks are recommended for outdoor cats.
## Prognosis and Expected Outcomes
The prognosis for pets treated with fluralaner is excellent when the product is used correctly. Clinical studies demonstrate high efficacy against both fleas and ticks for the full 12-week duration [1]. Most pets experience rapid relief from pruritus associated with flea bites, and existing infestations are typically cleared within days.
For pets with flea allergy dermatitis (FAD), the prognosis is particularly favorable. FAD is caused by a hypersensitivity reaction to flea saliva, and even a single flea bite can trigger intense itching. By providing continuous protection against fleas, fluralaner breaks the cycle of exposure and allows the skin to heal. Owners should expect improvement in clinical signs within one to two weeks, although secondary bacterial or fungal infections may require additional treatment.
For pets in areas with a high prevalence of tick-borne diseases, fluralaner significantly reduces the risk of infection. The rapid speed of kill minimizes the window for pathogen transmission. However, owners should remain vigilant for signs of tick-borne illness, including fever, lethargy, lameness, and decreased appetite. If any of these signs develop, the pet should be evaluated by a veterinarian, and tick-borne disease testing should be considered.
## Practical Administration Tips for Owners
### Administering the Chewable Tablet to Dogs
Bravecto chewable tablets are palatable, and most dogs will eat them readily. The tablet can be offered by hand or placed in a small amount of food. For dogs that are reluctant to take the tablet, it can be hidden in a treat or a small ball of cheese or peanut butter. Owners should ensure the entire tablet is consumed. If the dog spits out part of the tablet, the veterinarian should be contacted for advice.
### Administering the Spot-On to Cats
The feline spot-on should be applied directly to the skin at the base of the skull, just above the shoulder blades. This location is chosen because it is difficult for the cat to reach and groom. The owner should part the fur until the skin is visible, then apply the entire contents of the tube directly to the skin. The product should not be applied to the hair, as this reduces absorption. After application, the owner should wash their hands thoroughly with soap and water.
### Timing of Administration
The 12-week interval should be calculated from the date of administration. Owners may find it helpful to mark the calendar or set a reminder on their phone. If a dose is missed, it should be administered as soon as it is remembered, and the next dose should be scheduled 12 weeks from that date.
### Storage and Handling
Bravecto products should be stored at room temperature, away from direct sunlight and moisture. The products should be kept out of reach of children and pets. Expired products should be disposed of according to local regulations.
## When to Seek Immediate Veterinary Care
While fluralaner is generally safe, owners should be aware of the signs that require immediate veterinary attention. These include:
- Seizures, tremors, or muscle twitching
- Severe ataxia or inability to stand
- Profound lethargy or collapse
- Repeated vomiting or diarrhea, especially with signs of dehydration
- Facial swelling, hives, or difficulty breathing, which may indicate an allergic reaction
- In cats, excessive grooming or licking at the application site, which may indicate irritation
If any of these signs occur, the owner should contact a veterinary emergency facility immediately. The veterinarian may recommend supportive care, including intravenous fluids, antiemetics, or anticonvulsants, depending on the clinical signs.
## The Role of the Veterinarian in Ongoing Care
Fluralaner is a prescription product, and the veterinarian plays a central role in its use. The veterinarian is responsible for confirming the correct dose, providing administration instructions, and monitoring the pet for adverse effects. The veterinarian should also assess the pet's overall health at each visit and adjust the parasite prevention plan as needed.
Owners should be encouraged to maintain regular veterinary visits, at least annually, and to discuss any changes in their pet's health or lifestyle. A pet that begins spending more time outdoors, travels to a new geographic region, or develops a new medical condition may require a different parasite prevention strategy.
## Integrating Fluralaner into a Comprehensive Preventive Care Plan
Fluralaner is one component of a comprehensive preventive care plan. The veterinarian should also discuss heartworm prevention, intestinal parasite control, vaccination, and nutrition. A holistic approach to preventive care ensures that all aspects of the pet's health are addressed.
For heartworm prevention, fluralaner does not provide any activity against heartworms. A separate heartworm preventive is required. Many combination products are available, and the veterinarian can help the owner choose the most appropriate option based on the pet's lifestyle and risk factors.
For intestinal parasites, routine fecal examinations are recommended, and deworming may be necessary based on the results. Fluralaner has no activity against intestinal parasites, so a separate deworming protocol is required.
## Final Considerations for Pet Owners
Bravecto is a highly effective and convenient option for flea and tick control in dogs and cats. The 12-week duration of action reduces the frequency of dosing, which can improve compliance and ensure consistent protection. However, it is not a substitute for veterinary care, and it is not appropriate for every pet.
Owners should always consult with their veterinarian before starting any new medication. The veterinarian will confirm the correct dose, discuss potential risks, and provide guidance on administration and monitoring. By working together, the owner and veterinarian can ensure that the pet receives the best possible care and protection against fleas, ticks, and the diseases they transmit.
The evidence supporting fluralaner is strong, with published studies demonstrating efficacy against a range of tick species, including the Australian paralysis tick [1]. Ongoing research, including baseline susceptibility monitoring in cattle ticks, provides a framework for detecting any future resistance development [2]. For now, fluralaner remains a reliable and well-tolerated option for long-lasting ectoparasite control in companion animals.
## Frequently Asked Questions
### 1. What is the exact dose of Bravecto for my dog?
The target dose for dogs is 25 mg/kg body weight, administered orally. Your veterinarian will select the closest commercially available tablet size to your dog's exact weight.
### 2. What is the exact dose of Bravecto for my cat?
The target dose for cats is 40 mg/kg body weight, administered topically as a spot-on [1]. Your veterinarian will select the appropriate tube size for your cat's weight.
### 3. How long does a single dose of Bravecto last?
A single dose of fluralaner provides effective flea and tick control for 12 weeks (84 days) [1].
### 4. Does Bravecto kill the Australian paralysis tick?
Yes, a single topical administration of fluralaner at 40 mg/kg is effective against existing infestations of *Ixodes holocyclus* and provides sustained protection against re-infestation for 12 weeks [1].
### 5. Can I give Bravecto to my cat if I only have the dog chew?
No, absolutely not. Dog formulations are not safe for cats. You must use the specific feline spot-on product.
### 6. What should I do if my dog vomits after taking Bravecto?
If vomiting occurs within 2 hours of administration, the dose may not have been fully absorbed. Contact your veterinarian for advice on whether a re-dose is necessary.
### 7. Is Bravecto safe for dogs with a history of seizures?
There is a known association between isoxazoline drugs and neurological adverse effects, including seizures. The use of fluralaner in a pet with a seizure history requires a careful risk-benefit assessment by your veterinarian.
### 8. Can I bathe my cat after applying Bravecto spot-on?
It is recommended to wait at least 24 to 48 hours after application before bathing or allowing the cat to swim, to ensure the product is fully absorbed through the skin.
## Limitations and When to Contact a Veterinarian
**This article is educational and is not a substitute for veterinary diagnosis or treatment.**
The information provided here is a general guide. It does not replace the professional judgment of a licensed veterinarian. Breed-level information cannot predict the specific response of an individual animal to a drug. Always consult with your veterinarian to confirm the correct product, dose, and administration schedule for your pet.
## Sources
[1] [Investigation of the efficacy of fluralaner spot-on (Bravecto®) against infestations of Ixodes holocyclus on cats.](https://pubmed.ncbi.nlm.nih.gov/29941021/)
[2] [Standardization of larval bioassays for determination of fluralaner susceptibility in Rhipicephalus microplus.](https://pubmed.ncbi.nlm.nih.gov/40915046/)
## Related Clinical & Scientific Guides
* [Drontal Plus Dewormer: Broad-Spectrum Dose Guide by Weight](/knowledge/veterinary-medicine/calculators-clinical-tools/drontal-plus-dewormer-broad-spectrum-dose-guide-by-weight)
* [Panacur Fenbendazole Dewormer: Dog Fecal Parasite Treatment Schedule](/knowledge/veterinary-medicine/calculators-clinical-tools/panacur-fenbendazole-dewormer-dog-fecal-parasite-treatment-schedule)
* [Prednisolone for Cats: Feline Safe Steroid Dose and Autoimmune](/knowledge/veterinary-medicine/calculators-clinical-tools/prednisolone-for-cats-feline-safe-steroid-dose-and-autoimmune)